Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stieber

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Geburtshilfe Und Frauenheilkunde|December 1, 1989
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer]W Meier, W Eiermann, P Stieber, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1988
[Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer]W Meier, P Stieber, A Fateh-Moghadam, et al.
Anticancer Research|July 1, 1997
Prognostic significance of CA125 in patients with ovarian cancer and secondary debulking surgeryW Meier, P Stieber, U Hasholzner, et al.
Anticancer Research|July 1, 1997
CA125 based diagnosis and therapy in recurrent ovarian cancerW Meier, L Baumgartner, P Stieber, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
CA-125 in gynecological malignanciesW Meier, P Stieber, A Fateh-Moghadam, et al.
Gynakologische Rundschau|January 1, 1989
[The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer]W Meier, P Stieber, A Fateh-Moghadam, et al.
Anticancer Research|January 1, 1997
Anti-p53 antibodies in serum of smokers and head and neck cancer patientsB Wollenberg, N V Jan, P Pitzke, et al.
Anticancer Research|September 2, 1999
CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC)P Stieber, A Zimmermann, J Reinmiedl, et al.
Zeitschrift Fur Gastroenterologie|October 16, 1999
[Carbohydrate-deficient transferrin (CDT) is modified by iron status: further reservations regarding the value of a new alcohol marker?]M Bilzer, U M Schmitt, P Stieber, et al.
Anticancer Research|September 2, 1999
CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancerU Hasholzner, P Stieber, W Reiter, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Geburtshilfe Und Frauenheilkunde|December 1, 1989
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer]W Meier, W Eiermann, P Stieber, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1988
[Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer]W Meier, P Stieber, A Fateh-Moghadam, et al.
Anticancer Research|July 1, 1997
Prognostic significance of CA125 in patients with ovarian cancer and secondary debulking surgeryW Meier, P Stieber, U Hasholzner, et al.
Anticancer Research|July 1, 1997
CA125 based diagnosis and therapy in recurrent ovarian cancerW Meier, L Baumgartner, P Stieber, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
CA-125 in gynecological malignanciesW Meier, P Stieber, A Fateh-Moghadam, et al.
Gynakologische Rundschau|January 1, 1989
[The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer]W Meier, P Stieber, A Fateh-Moghadam, et al.
Anticancer Research|January 1, 1997
Anti-p53 antibodies in serum of smokers and head and neck cancer patientsB Wollenberg, N V Jan, P Pitzke, et al.
Anticancer Research|September 2, 1999
CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC)P Stieber, A Zimmermann, J Reinmiedl, et al.
Zeitschrift Fur Gastroenterologie|October 16, 1999
[Carbohydrate-deficient transferrin (CDT) is modified by iron status: further reservations regarding the value of a new alcohol marker?]M Bilzer, U M Schmitt, P Stieber, et al.
Anticancer Research|September 2, 1999
CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancerU Hasholzner, P Stieber, W Reiter, et al.
Pageof 9